Office of the Secretary; Notice of Meeting, 104194-104195 [2024-30338]
Download as PDF
<![CDATA[
104194
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
Agenda: Program Updates, Clearance of
Concepts.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850,
(Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D.,Executive Secretary, National Center
for Advancing Translational Sciences, 9609
Medical Center Drive, Room 1E454,
Rockville, MD 20850, anna.ramseyewing@
nih.gov, (301) 435–0809.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting at NCATSCouncilInput@
mail.nih.gov. The statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
ncats.nih.gov/advisory/council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–30325 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be held as a virtual
meeting and is partially open to the
public as indicated below. Individuals
who plan to view the virtual meeting
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
and need special assistance to view the
meeting, such as sign language
interpretation or other reasonable
accommodations, should notify Ms.
Karon Yarborough (karon.yarborough@
nih.gov) or use the Federal Relay, 1–
800–877–8339, in advance of the
meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting website (https://
videocast.nih.gov/). Registration is not
required to access the videocast.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: January 22, 2025.
Open: 10:00 a.m. to 1:15 p.m.
Agenda: Report of the Director, NIDCR and
concept clearances.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Closed: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate BSC
report to council.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Closed: 2:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yasaman Shirazi, Ph.D.,
Branch Chief, National Institute of Dental &
Craniofacial Research, National Institutes of
Health, 31 Center Drive, Bethesda, MD
20892, 301–594–5593, Email:
yasaman.shirazi@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about-us/advisorycommittees/advisory-council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
PO 00000
Frm 00123
Fmt 4703
Sfmt 4703
Dated: December 17, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30446 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Autism
Coordinating Committee.
The meeting will be virtually held
and is open to public viewing. The
connection information and how to
access the meeting will be available on
the IACC website https://iacc.hhs.gov/
meetings/iacc-meetings/2025/summaryof-advances/january14/. Advanced
registration is recommended.
Individuals wishing to participate
virtually that need special assistance or
other reasonable accommodations
should submit a request to the Contact
Person listed on this notice at least
seven (7) business days prior to the
meeting.
The purpose of the IACC meeting is
to discuss the committee’s nominations
of articles for the 2024 IACC Summary
of Advances in Autism Research report.
The final report will summarize the top
20 advances in autism biomedical and
services research, as selected by the
IACC.
Name of Committee: Interagency Autism
Coordinating Committee 2024 IACC
Summary of Advances in Autism Research.
Date: January 14, 2025.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To discuss the committee’s
nominations of articles for the 2024 IACC
Summary of Advances in Autism Research
report.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC website
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended.
Contact Person: Ms. Rebecca Martin, Office
of National Autism Coordination, National
Institute of Mental Health, NIH, Phone: 301–
435–0886.
Email: IACCPublicInquiries@
mail.nih.gov.
Technical issues: If you experience
any technical problems with the zoom
E:\FR\FM\20DEN1.SGM
20DEN1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
webcast, please email
IACCPublicInquiries@mail.nih.gov.
Disability Accommodations: All IACC
Full Committee Meetings provide
Closed Captioning through the Zoom
platform. Individuals whose full
participation in the meeting will require
special accommodations (e.g., sign
language or interpreting services, etc.)
must submit a request to the Contact
Person listed on the notice at least seven
(7) business days prior to the meeting.
Such requests should include a detailed
description of the accommodation
needed and a way for the IACC to
contact the requester if more
information is needed to fill the request.
Special requests should be made at least
seven (7) business days prior to the
meeting; last-minute requests may be
made but may not be possible to
accommodate.
Meeting schedule subject to change.
More Information
Information about the IACC is
available on the website: https://
www.iacc.hhs.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person. In
the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Dated: December 16, 2024.
David W Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–30338 Filed 12–19–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications
and contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Diet, Lipid
Metabolism, and Cancer.
Date: January 30, 2025.
Time: 9:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W248, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer ,Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248 Rockville,
Maryland 20850, 240–672–6175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–5: NCI
Clinical and Translational Cancer Research.
Date: February 12, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W248, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer ,Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248 Rockville,
Maryland 20850, 240–672–6175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; RNA
Modifications Driving Oncogenesis
(RNAMoDO; U01 Clinical Trial Not
Allowed).
Date: February 14, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W260, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Robert F. Gahl, Ph.D.,
Scientific Review Officer, Special Review
Branch ,Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical
Center Drive, Room 7W260 Rockville,
Maryland 20850, 240–276–7869, robert.gahl@
nih.gov.
PO 00000
Frm 00124
Fmt 4703
Sfmt 4703
104195
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Prevention Clinical Trials Network—Sites
and Data Management.
Date: February 14, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W108, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–12:
NCI Clinical and Translational Cancer
Research.
Date: February 14, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W244, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Amr M. Ghaleb, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244,
Rockville, Maryland 20850, 240–276–6611,
amr.ghaleb@nih.gov
Name of Committee: National Cancer
Institute Initial Review Group; Career
Development Study Section (J).
Date: February 19–20, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W624, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Tushar Deb, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W624, Rockville, Maryland 20850,
240–276–6132, tushar.deb@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SBIR
Concept Award TEP.
Date: February 21, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove 9609 Medical Center Drive,
Room 7W608, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104194-104195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30338]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Interagency Autism
Coordinating Committee.
The meeting will be virtually held and is open to public viewing.
The connection information and how to access the meeting will be
available on the IACC website https://iacc.hhs.gov/meetings/iacc-meetings/2025/summary-of-advances/january14/. Advanced registration is
recommended. Individuals wishing to participate virtually that need
special assistance or other reasonable accommodations should submit a
request to the Contact Person listed on this notice at least seven (7)
business days prior to the meeting.
The purpose of the IACC meeting is to discuss the committee's
nominations of articles for the 2024 IACC Summary of Advances in Autism
Research report. The final report will summarize the top 20 advances in
autism biomedical and services research, as selected by the IACC.
Name of Committee: Interagency Autism Coordinating Committee
2024 IACC Summary of Advances in Autism Research.
Date: January 14, 2025.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To discuss the committee's nominations of articles for
the 2024 IACC Summary of Advances in Autism Research report.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Cost: The meeting is free and open to the public.
Registration: A registration web link will be posted on the IACC
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is
recommended.
Contact Person: Ms. Rebecca Martin, Office of National Autism
Coordination, National Institute of Mental Health, NIH, Phone: 301-
435-0886.
Email: [email protected].
Technical issues: If you experience any technical problems with the
zoom
[[Page 104195]]
webcast, please email [email protected].
Disability Accommodations: All IACC Full Committee Meetings provide
Closed Captioning through the Zoom platform. Individuals whose full
participation in the meeting will require special accommodations (e.g.,
sign language or interpreting services, etc.) must submit a request to
the Contact Person listed on the notice at least seven (7) business
days prior to the meeting. Such requests should include a detailed
description of the accommodation needed and a way for the IACC to
contact the requester if more information is needed to fill the
request. Special requests should be made at least seven (7) business
days prior to the meeting; last-minute requests may be made but may not
be possible to accommodate.
Meeting schedule subject to change.
More Information
Information about the IACC is available on the website: https://www.iacc.hhs.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. In the interest of security, NIH has procedures
at https://www.nih.gov/about-nih/visitor-information/campus-access-security for entrance into on-campus and off-campus facilities. All
visitor vehicles, including taxicabs, hotel, and airport shuttles will
be inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked to
show one form of identification (for example, a government-issued photo
ID, driver's license, or passport) and to state the purpose of their
visit.
Dated: December 16, 2024.
David W Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-30338 Filed 12-19-24; 8:45 am]
BILLING CODE 4140-01-P
